MedTrace Logo

GECo: Implementation and Effectiveness of COPD Self Management Action Plans in Low and Middle Income Countries

NCT03359915 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2017-12-04

No results posted yet for this study

Summary

This study will randomise people with clinically significant COPD (GOLD Grade B-D) to usual care or provision of a self-management action plan supported by monthly follow-up visits from a community health worker trained in the use of the action plan. The primary outcome will be health-status: a comparison of the change in St. George's Respiratory Questionnaire (SGRQ) between baseline and 12 months in the two groups. We will randomise 240 people from three low- and middle-income countries, namely Nepal, Peru and Uganda. We will also examine the feasibility of implementing our self-management action plan intervention at scale.

Conditions

Interventions

BEHAVIORAL

COPD Self-Management Plan

Patient education in use of a COPD self-management action plan supported by monthly visits from, and access to, a CHW who has been trained in the use of a COPD self-management action plan.

Sponsors & Collaborators

  • Johns Hopkins University

    collaborator OTHER

  • Universidad Peruana Cayetano Heredia

    collaborator OTHER

  • Asociacion Benefica Prisma

    collaborator OTHER

  • Makerere University

    collaborator OTHER

  • University of York

    collaborator OTHER

  • Institute of Medicine, Tribhuvan University, Nepal

    collaborator UNKNOWN

  • University College, London

    lead OTHER

Principal Investigators

  • John R Hurst, FRCP, PhD · University College, London

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-12-31
Primary Completion
2019-11-30
Completion
2020-02-29

Countries

  • Nepal
  • Peru
  • Uganda

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03359915 on ClinicalTrials.gov